Home » Glenmark, Merck Settle Patent Row Over Cholesterol Drug
Glenmark, Merck Settle Patent Row Over Cholesterol Drug
Merck & Co and Glenmark Pharmaceuticals have reached an agreement to settle their patent litigation involving the former’s patent covering Zetia (ezetimibe), which is used to treat high cholesterol, the companies said in a filing to the stock exchanges Tuesday.
Business Standard
Business Standard
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May